4//SEC Filing
MLS Capital Fund II LP 4
Accession 0000950170-23-034900
CIK 0001822691other
Filed
Jul 25, 8:00 PM ET
Accepted
Jul 26, 8:34 PM ET
Size
6.1 KB
Accession
0000950170-23-034900
Insider Transaction Report
Form 4
Transactions
- Other
Common Stock, par value $0.0001 per share
2023-07-24−5,818,575→ 0 total
Footnotes (1)
- [F1]Pursuant to the Contribution and Exchange Agreement dated May 29, 2023 between GreenLight Biosciences Parent, PBC ("Parent") and MLS Capital Fund II, L.P., MLS Capital Fund II, L.P. contributed its shares of common stock of the Issuer to Parent in exchange for shares of Series A-2 Preferred Stock, par value $0.0001 per share, of Parent in connection with the closing of the transactions contemplated by the Agreement and Plan of Merger, dated May 29, 2023, by and among Issuer, Parent and SW MergerCo, Inc. ("Merger Sub") on July 24, 2023, pursuant to which Merger Sub merged with and into the Issuer, with the Issuer surviving as a wholly-owned subsidiary of Parent.
Documents
Issuer
GreenLight Biosciences Holdings, PBC
CIK 0001822691
Entity typeother
IncorporatedMalaysia
Related Parties
1- filerCIK 0001624476
Filing Metadata
- Form type
- 4
- Filed
- Jul 25, 8:00 PM ET
- Accepted
- Jul 26, 8:34 PM ET
- Size
- 6.1 KB